ABSTRACT: Several clostridial vaccines are currently being used in the beef cattle industry. Of greatest concern is altering the location and route of administration of these vaccines to reduce injection-site lesions while maintaining seroconversion. Two experiments were conducted to determine the effect of clostridial vaccines and injection sites on the performance, feeding behavior, and lesion size scores of beef steers. In Exp. 1, 80 crossbred beef steers (BW 237 ± 3.2 kg) were allotted randomly into five groups and given 14 d to adapt to the feed and individual feed intake-monitoring devices (Pinpointer devices) before starting the study. Each group was assigned randomly to one of the following vaccination treatments: 1) control (sterile saline water), 2) Alpha-7 Ear (A7E), 3) Alpha-7 Prescapula (A7P), 4) Vision-7 Prescapula (V7P), and 5) Ultrabac-7 Prescapula (U7P). All vaccines were injected s.c. in the ear or prescapular region, and injection sites were palpated on d 0 and 28 (Exp. 1) and on d 63 and 91 (Exp. 2). The protocol for Exp. 2 was exactly the same
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as for Exp. 1 except treatments included control, A7P, Alpha-CD Ear (ACDE), Alpha-CD Prescapula (ACDP), Fortress-7 Prescapula (F7P), and V7P. Also, control and steers receiving F7P and V7P were revaccinated on d 63 and palpated on d 91. Results of Exp. 1 indicated that the A7E and U7P steers had a feed intake lower (P < 0.01) than all other treatment groups. The ADG of the A7P and A7E steers were not different (P > 0.05) from those of the control steers. The gain:feed ratio of the A7E steers was 41% higher (P < 0.01) than that of the V7P steers (Exp. 1). The results of Exp. 2 indicated that the control, ACDP, and V7P steers had greater (P < 0.01) ADG than all other treatment groups, but the gain:feed ratios were not different (P > 0.05) among all treatment groups. Lesion sizes differed by vaccine and injection site in both experiments. These data suggest that vaccinating beef steers s.c. in the ear produced gain:feed ratios and lesion size scores that were similar to prescapular vaccinations. However, more research is required to determine the immune response of vaccinating cattle in the ear.
factors including type of vaccine, route or site of vaccination, and the adjuvant used. Several clostridial vaccines are currently being used in the beef cattle industry with economic concern regarding the effects of injection site lesions on growth performance, seroconversion, and meat quality. The National Cattlemen's Beef Association conducted the National Beef Quality Audit (Smith et al., 1992) and reported that the top 10 concerns of retailers, foodservice industry, and packers included the high incidence of injection site blemishes. Therefore, Smith et al. (1992) generated an awareness among producers and researchers of the problems associated with the use of vaccines in beef production. George et al. (1995) reported that 93.2 to 99.9% of all lesions reported for retail and purveyor audits, respectively, were chronologically aged lesions, suggesting that these lesions resulted from injections during weaning, stocker, and finishing phases. Probably, the incidence of noticeable clostridial injection site lesions or blemishes and tissue reactions is becoming prevalent because of the development of new and powerful vaccines, the s.c. route of administration, and the location of the injection site on the animal. However, the effects of the lesions or blemishes on the performance of cattle are not well documented. These experiments were designed to investigate the effects of various clostridial vaccines and injection sites on the performance, feeding behavior, and lesion size scores of beef steers.
Materials and Methods
Animals and Housing. In Exp. 1, 80 crossbred steers (BW 237 ± 3.2 kg) were purchased by a commercial cattle order buyer at an auction market in San Angelo and transported by truck to the Texas Agricultural Experiment Station and USDA/Agricultural Research Service beef cattle research facilities in Bushland, TX. All steers were ranked by initial BW, and the heaviest and lightest steers were deleted from a group of 120 steers to provide a uniform group yielding no significance difference (P > 0.05) in initial BW among treatment groups. Upon arrival, all the steers were weighed and tagged in the ear with individual identification numbers. The steers were vaccinated against bovine virus diarrhea, parainfluenza, bovine respiratory syncytial virus, and infectious bovine rhinotracheitis virus using Bovishield 4 (Pfizer Animal Health, New York, NY) and treated with an anthelmintic (Ivomec; Merck and Co. Inc., Rahway, NJ) for internal and external parasites. Steers also received injectable vitamins A and D and fortified vitamin B complex (RXV Products, New York, NY). All drugs were used according to label directions. All the steers were palpated for preexisting implants, and all such implants were removed before starting the experiments.
The steers were housed in outdoor pens equipped with computerized individual feed intake monitoring devices (Pinpointer; AIS Corp., Cookeville, TN) without cover. The Pinpointer devices also measured the daily number of visits to the feeder and the time spent eating by each steer. Before initiating the experiment, the steers were adapted to the diet and monitoring devices for 14 d. The diet fed to the steers in Exp. 1 is presented in Table 1 . The diet was formulated to meet or exceed the nutrient requirements of growing beef steers (NRC, 1984) , and steers had free access to diets and water.
During the course of the study, an independent veterinarian blind to the treatments checked the steers at 0700. Using the procedure reported by Orr et al. (1990) , morbid steers were identified and treated with Micotil (Elanco Animal Health, Indianapolis, IN) when they were first identified as morbid, and then treated with Erythromycin l (Sanofi-Synthelabo Inc., New York, NY) when they became morbid the second time. One steer from the control group was identified as morbid (Exp. 2) for a third time and therefore was treated with Naxcel (Pharmacia & Upjohn Animal Health, Kalamazoo, MI), which it had not received previously. All drugs were used according to label directions. Experimental Design. A completely randomized design was used in this study. Cattle were allotted randomly to treatment groups on the basis of initial BW and assigned randomly to each Pinpointer pen. There were 16 steers per treatment. The clostridial vaccine treatments were 1) control (sterile water in prescapula by s.c. injection), 2) Alpha-7 in the prescapula by s.c. injection (A7P; Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO), 3) Alpha-7 in the ear by s.c. injection (A7E; Boehringer Ingelheim Vetmedica, Inc.), 4) Vision-7 in the prescapula by s.c. injection (V7P; Bayer Corporation, Pittsburgh, PA), and 5) Ultrabac-7 in the prescapula by s.c. injection (U7P; Pfizer Animal Health, New York). All the vaccines were given in a single dose according to label directions. The V7P and U7P treatment groups received booster vaccinations on d 28 of the experiment. The clostridial treatments were assigned randomly to each pen. Individual body weights were recorded in the beginning (d 0) and final day (d 28) of the study. Injection site lesions were palpated on d 28 by an experienced independent veterinarian blinded to the treatments. Lesion sizes were palpated and scored according to the following categorization: 0 = no lesion, 1 = 2.5 to 5 mm in diameter, 2 = 5 to 10 mm in diameter, 3 = 10 to 15 mm in diameter, and 4 = greater than 15 mm in diameter. The procedures of Exp. 2 were the same as those of Exp. 1, except that there was a total of 96 crossbred steers (average BW 296 kg) in this experiment. The clostridial vaccines and injection site treatments included 1) control, sterile water in the prescapula by Statistical Analysis. All the data (Exp. 1 and 2) were subjected to the analysis of variance using the GLM procedures of SAS (SAS Inst., Inc., Cary, NC). Analysis of variance was performed using steer as both a sampling and an experimental unit. The model specified for this analysis is given as Y ijk = µ + T i + ID(T i ) + ε ijk , where Y ijk = feed intake, ADG, gain:feed, eating time, meal size, eating rate, and time/visit; µ is the overall mean; T i is the treatment effect; ID(T i ) is animal within treatment (covariate), and ε ijk is the experimental error. When there were main effects of vaccine, the means were separated by Duncan's multiple-range test (Steel and Torrie, 1980) . Lesion size data were summarized as the percentage of lesions present within each treatment group at the time of palpation since the cell sizes were too small for Chi-square analysis.
Results and Discussion
Animal Performance. From Exp. 1, the control-, A7P-, and V7P-vaccinated groups consumed more (P < 0.01) feed than those vaccinated with A7E or U7P ( Table 3) . The ADG for the control steers was higher (P < 0.05) than for both the V7P-and U7P-treated groups (1.43 vs 1.04 and 1.14 kg/d, respectively), with both Alpha-7-vaccinated groups being intermediate, regardless of site of injection. The fact that the feed intakes for A7P and V7P were not different from the intake for controls suggests that these vaccines did not impair feed intake. However, the ADG was reduced in both the V7P-and Control (sterile water), injected subcutaneous (s.c.), prescapula. A7P = Alpha-7, injected s.c, prescapula. A7E = Alpha-7, injected s.c., ear. V7P = Vision-7, injected s.c., prescapula. U7P = Ultra-7, injected s.c., prescapula. U7P-vaccinated steers when compared with the controls. The gain:feed ratio (G:F) for the control-, A7E-, A7P-, and U7P-vaccinated steers were higher (P < 0.01) than that for the V7P group. The lower G:F observed in the V7P group was an indication of their very low rate of gain during the entire study (Table 3) .
Although not significant (P > 0.05), between the Alpha-7 clostridial-vaccinated groups, those vaccinated in the ear utilized 15.7% less feed (5.9 vs 7.0) per kilogram of BW gained than those vaccinated in the prescapular region (Table 3 ). This improvement in feed conversion simply by relocation of the injection site to an economically less valuable part of the animal could become valuable to producers if there is a concomitant Control (sterile water), injected subcutaneous (s.c), prescapula. A7P = Alpha-7, injected s.c., prescapula. ACDP = Alpha-7 CD, injected s.c., prescapula. ACDE = Alpha-7 CD, injected s.c., ear. F7P = Fortress-7, injected s.c., prescapula. V7P = Vision-7, injected s.c., prescapula. Means within the same row with different superscripts differ (P < 0.01).
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Means within the same row with different superscripts differ (P < 0.04). similar seroconversion to vaccine in both the ear-and prescapular-vaccinated groups. More importantly, the ADG and G:F of the control steers and steers vaccinated in the ear (A7E) were not different (P > 0.05), suggesting that ear vaccination did not impair animal performance in this experiment.
The performance results for Exp. 2 are presented in Table 4 . On d 119, the control and ACDP steers were heavier (P < 0.01) than the ACDE steers. All other treatment groups were intermediate. Steers vaccinated with ACDP had the highest (P < 0.01) feed intake of all the groups (Table 4) , with those vaccinated with A7P, ACDE, and F7P having the lowest feed intake. The ADG for the control, ACDP, and V7P steers were greater (P < 0.01) than those of A7P, ACDE, and F7P steers (Table 4 ). The G:F were not different (P > 0.05) among treatments in this experiment.
In Exp. 2, steers that were vaccinated in the ear consumed less feed (9.3 vs 10.3 kg/d) and gained less (1.30 vs 1.43 kg/d) than those vaccinated in the prescapular region (Table 4) , but the G:F were not different (P > 0.05). This observation agrees with those of Exp. 1. Although vaccinating cattle in the ear produces minimum reduction in performance and no damage to the hide, the data presented are insufficient to conclude that the same seroconversion rates will be achieved as when vaccinating in the prescapular region.
Although there have been several studies (Smith et al., 1992; Dexter et al., 1994; George et al., 1995) that addressed postharvest concerns of vaccine types and injection site lesions on the economic value of beef, these data suggest a novel approach to vaccine delivery with minimal reduction in performance and postharvest value. Clostridial vaccine injection sites are notorious for being unsightly because of the lesion size and location of vaccination (George et al., 1984) ; therefore, relocating the vaccine site to the ear could reduce the concerns of producers especially if cattle are marketed prior to being finished at the feedlot.
Feeding Behavior. The results of the feed consumption behavior of all treatment groups of Exp. 1 are presented in Table 3 . Steers vaccinated with A7E exhibited the lowest (P < 0.01) number of visits per day than all other treatment groups. However, the V7P and U7P steers made more visits (P < 0.05) to the Pinpointer feeder than the control steers. When different injection sites for the same vaccine were compared, steers vaccinated in the ear made fewer (P < 0.01) visits than those vaccinated in the prescapular region. The significant reduction in the number of visits by the steers vaccinated in the ear is reflected in the decrease in feed intake and the consequent 13.3% improvement in G:F of this group when compared with those vaccinated prescapularly ( Table 3) .
The A7P-, V7P-, and U7P-accinated steers spent more (P < 0.05) time each day acquiring feed than the control and A7E steers. Furthermore, the A7E steers spent 28.8% less (P < 0.01) time in a day than the control c.) , prescapula. A7P = Alpha-7, injected s.c., prescapula. A7E = Alpha-7 CD, injected s.c., ear. V7P = Fortress-7, injected s.c., prescapula. U7P = Vision-7, injected s.c., prescapula.
steers (18.8 vs 26.4 min/d, respectively) . The meal sizes of all treatment groups were different (P < 0.05), with the A7E group having the largest meal size, suggesting that the fewer the number of visits and the lesser the time spent eating in a day, the larger the meal size. By consuming smaller meals and making greater numbers of visits or consuming larger meals at few visits, steers will acquire feed to meet their energy needs. Consequently, the A7E-vaccinated steers exhibited a much higher (P < 0.01) eating rate than all other steers (Table  3) . Physiologically, small meals spread throughout the day might improve the efficiency of nutrient metabolism in the rumen (Argenzio, 1993 ) than large meals consumed within a short period of time, but the G:F, especially that of the A7E treatment group, contrasts sharply with this fact (Table 3) . The difference could be that high-concentrate diets require less rumination time (Leek, 1993) and therefore large meal sizes consumed within a short period were utilized as efficiently as small meals spread throughout the day.
The A7E steers spent the greatest (P < 0.01) amount of time per visit of all treatment groups, with the V7P and U7P steers spending the least amount of time per visit (Table 3 ). Both the control-and the A7E-vaccinated steers spent similar amount of time per visit but were still greater (P < 0.01) than both the V7P-and U7P-vaccinated steers (Table 3) .
The results of the feed consumption behavior of all treatment groups of Exp. 2 are presented in Table 4 . The ACDE steers made more visits (P < 0.01) to the feed bunk than all other groups. The ACDP and V7P steers made least (P < 0.01) number of visits to the feed bunk than all other groups (Table 4) . Steers vaccinated with A7P spent the most (P < 0.05) amount of time eating per day than all other treatment groups, which averaged 19.6 min/d but were not different (Table 4) .
The ACDP-vaccinated steers had the largest (P < 0.01) meal size of all the groups and the ACDE steers had the smallest meal size. Other groups were intermediate. The ACDP and V7P steers had greater (P < 0.05) eating rates than all other treatment groups (Table 4) . These observations agree with those of Exp. 1, suggesting that the steers tended to compensate for lower numbers of visits to the Pinpointer feeder by increasing Control (sterile water), injected subcutaneous (s.c.), prescapula. A7P = Alpha-7, injected s.c., prescapula. ACDP = Alpha-7 CD, injected s.c., prescapula. ACDE = Alpha-7 CD, injected s.c., ear. F7P = Fortress-7, injected s.c., prescapula. V7P = Vision-7, injected s.c., prescapula. their feed consumption rate or increasing the time spent eating.
The location of the injection (prescapula vs ear) influenced (P < 0.01) the total number of visits to the feeder but did not affect (P > 0.05) the time spent eating (Table 4) . Steers vaccinated in the prescapular region had larger (P < 0.05) meal sizes than those vaccinated in the ear. Similarly, these steers also had greater eating rates than those vaccinated in the ear. These observations also agree with those of Exp. 1.
The A7P-vaccinated steers spent the greatest (P < 0.01) amount of time per visit, which was almost twice the amount of time spent per visit by the control and ACDE steers (Table 4) . Within the same vaccine group, steers vaccinated in the ear spent less time per visit than those vaccinated in the prescapular area. This observation also agrees with that of Exp. 1.
Lesion Size Scores.
The results of the lesion size scores of steers vaccinated with various clostridial vaccines for Exp. 1 are presented in Table 5 . On d 28, the control steers had no signs of lesions. The A7P, V7P, and U7P treatment groups had 3, 2, and 1 steers, respectively, that were determined as either non-respondents or the lesions subsided before the d-28 palpation. All the A7E steers responded to the vaccine with lesion sizes varying from 2.5 to 15 mm in diameter. The largest lesion size (> 15 mm) response was measured in 6.3% of the steers of the A7P treatment group (Table 5 ). The next- c.) , prescapula. A7P = Alpha-7, injected s.c., prescapula. ACDP = Alpha-7 CD, injected s.c., prescapula. ACDE = Alpha-7 CD, injected s.c., ear. F7P = Fortress-7, injected s.c., prescapula. V7P = Vision-7, injected s.c., prescapula. largest lesion size measurement (10 to 15 mm) occurred in 2, 6, 2, and 4 of the steers in the A7P, A7E, V7P, and U7P treatment groups, respectively. Vaccinating in the ear produced 18.6% more animals that responded with detectable lesions by d 28 than the prescapular injection, indicating that clostridial vaccination in the ear was efficacious in producing lesions.
The results of the lesion size scores of steers vaccinated with different clostridial vaccines at different injection sites for Exp. 2 are presented in Tables 6 and  7 . On the d-28 palpation (Table 6 ), all the steers in the control group indicated no lesions, which agrees with the observations of Exp. 1. The largest proportion of steers indicating no response during this time period occurred in the F7P treatment group (87.5%), with the least proportion (18.7%) of steers occurring in the ACDE group. The largest lesion size (10 to 15 mm in diameter) was measured in 6.3% of all the steers in the A7P, ACDP, and ACDE treatment groups. By the d-63 palpation, 6.3% of the steers in the A7P treatment group (Exp. 2) still had lesion sizes with diameters of 10 to 15 mm (Table 7) . The control and F7P steers showed no detectable lesions at the d-63 palpation (Table 7) . By d 63, 18.6, 62.5, and 43.7% of the A7P, ACDP, and ACDE steers, respectively, indicated lesions that had subsided or were not detectable. Within the same vaccine, ear vaccination sustained the response beyond d 63 but slightly less longer than the A7P group (Table 7) . The results of the lesion scores of the control, F7P, and V7P steers are presented in Figure 3 . On the d-91 palpation, the respondents to the booster vaccination of control, F7P, and V7P steers were 0, 6.3, and 87.5%, respectively. The highest proportion of respondents was detected in the V7P treatment group, with lesion sizes in diameter ranging from 2.5 to 5 mm. This same group had the second-largest number of respondents (12.5%) with lesions sizes in diameters of 10 to 15 mm (Figure 3) .
Implications
The location of the site of injection of clostridial vaccines on beef cattle may be important not only because of the seroconversion and damage to the carcass evident at slaughter, but also because of the decrease in performance during the early part of the finishing program. Subcutaneous vaccination in the ear produced performance that was not different from prescapular vaccination. Although vaccinating steers in the ear produced a greater proportion of respondents as measured by lesion size score than did prescapular vaccination, the corresponding immune response was not measured. The injection site for certain clostridial vaccines could be relocated from the classical or currently recommended areas to the ear with minimal effects on performance. However, the immune response should be measured by antibody titers to ensure that seroconversion has been achieved.
